BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Febuxostat

A thiazole derivative and inhibitor of XANTHINE OXIDASE that is used for the treatment of HYPERURICEMIA in patients with chronic GOUT.

297+ PubMed studies analyzed · 64 RCTs · Evidence Score: 60

Research Domains

Febuxostat has been studied across 15 research domains including 🫘 Kidney, ❤️ Cardiovascular, 🔬 Inflammation, 🔬 Oncology, 🫁 Liver & Detox. The primary research focus is 🫘 Kidney with 24% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Febuxostat, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Finasteride
11 shared targets
Carboxin
9 shared targets
Linuron
8 shared targets
Leflunomide
15 shared targets
Thiabendazole
10 shared targets
Phenelzine
11 shared targets
2-Acetylaminofluorene
10 shared targets
Secologanin
9 shared targets
Idazoxan
12 shared targets
Azathioprine
11 shared targets
Loading evidence profile...

This evidence profile for Febuxostat is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.